The Mycology Laboratory serves as a comprehensive reference facility for all NYSDOH licensed clinical laboratories including: hospitals, academic medical centers, county health departments and commercial laboratories.
The laboratory also administers a NYS Public Health Law, and Federal CLIA ’92 mandated proficiency testing (PT) program for laboratories licensed to test fungal specimens that originated from New York residents.
The laboratory houses a fungal culture collection repository, an outstanding resource for assay development, distribution and sale.
Research and development efforts complement diagnostic and PT programs by focusing on innovations in fungal diagnostics and antifungal testing, mechanisms of fungal pathogenesis, and molecular epidemiology. These activities are carried out in collaboration with scientists at the Wadsworth Center and investigators from around the globe. Excellent opportunities are available for the training of undergraduate, graduate students, post-doctoral fellows and clinical laboratory personnel.
The Wadsworth Center Mycology Laboratory has a long history of excellence in both basic and applied research. The laboratory has made many notable contributions to the field with the most famous being the discoveries of the antifungal drug ‘nystatin’ by Drs. Rachel Fuller Brown and Elizabeth Lee Hazen, and the cryptococcal latex agglutination test by Dr. Morris Gordon.
NYSDOH Wadsworth Center is One of Only Seven in the US Designated by CDC as Antimicrobial Resistance (AR) Regional Laboratories
On August 3, 2016 New York State Commissioner of Health Dr. Howard A. Zucker announced the Wadsworth Center has been awarded $1.8 million to serve as one of seven labs in the nation designated as an Antimicrobial Resistance (AR) Regional Laboratory. These laboratories, strategically placed...read more